Halozyme Therapeutics, Inc. (HALO)

68.79 +2.15 (+3.23%) USD  |  NASDAQ  |  Apr 17, 12:01
More

Halozyme Therapeutics FCF to Assets (TTM)

FCF to Assets (TTM) Chart

View FCF to Assets (TTM) for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View FCF to Assets (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

FCF to Assets (TTM) Range, Past 5 Years

View FCF to Assets (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

FCF to Assets (TTM) Benchmarks

View FCF to Assets (TTM) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Glaukos Corp. Upgrade
Agenus, Inc. Upgrade